Mitral StenosisSymptoms, Doctors, Treatments, Advances & More
Learn About Mitral Stenosis
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Massachusetts General Hospital
Judy Hung is a Cardiologist practicing medicine in Boston, Massachusetts. Dr. Hung is rated as an Elite provider by MediFind in the treatment of Mitral Stenosis. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Mitral Stenosis, Mitral Valve Regurgitation, Aortic Valve Stenosis, Aortic Valve Replacement, and Patent Foramen Ovale Repair.
MN - Heart Valve
Mackram Eleid is an Interventional Cardiologist practicing medicine in Rochester, Minnesota. Dr. Eleid is rated as an Elite provider by MediFind in the treatment of Mitral Stenosis. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Tricuspid Regurgitation, Mitral Valve Regurgitation, Aortic Valve Stenosis, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).
MN - Heart Valve
Sorin Pislaru is a Cardiologist practicing medicine in Rochester, Minnesota. Dr. Pislaru is rated as an Elite provider by MediFind in the treatment of Mitral Stenosis. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Tricuspid Regurgitation, Aortic Valve Stenosis, Mitral Stenosis, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).
Summary: This prospective observational study aims to investigate the impact of transcatheter aortic valve implantation (TAVI) and transcatheter mitral valve edge-to-edge repair (M-TEER) on sleep-disordered breathing (SDB) in patients with significant valvular heart disease. Patients undergoing TAVI or M-TEER will be evaluated with full polysomnography prior to the intervention and at 6 months follow-up. C...
Summary: The objective of this study is to evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral valve disease (including mitral regurgitation, mitral stenosis and mixed mitral valve disease) in whom transcatheter therapy is deemed more appropriate than open heart surgery.